Hudson Executive Capital LP recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
1185 Avenue Of The Americas, 32nd Floor New York, NY 10036
As of the latest 13F report, the guru’s equity portfolio contained 7 stocks valued at a total of $939.00Mil. The top holdings were DB(81.32%), VRAY(7.51%), and CTLP(5.67%).
According to GuruFocus data, these were Hudson Executive Capital LP’s top five trades of the quarter.
Akoya Biosciences Inc
Hudson Executive Capital LP reduced their investment in NAS:AKYA by 322,304 shares. The trade had a 0.41% impact on the equity portfolio. During the quarter, the stock traded for an average price of $11.99.
On 02/17/2023, Akoya Biosciences Inc traded for a price of $12.365 per share and a market cap of $469.32Mil. The stock has returned 7.11% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, Akoya Biosciences Inc has a price-book ratio of 6.24, a EV-to-Ebitda ratio of -7.71 and a price-sales ratio of 6.66.
Natera Inc
Hudson Executive Capital LP reduced their investment in NAS:NTRA by 210,297 shares. The trade had a 1.32% impact on the equity portfolio. During the quarter, the stock traded for an average price of $41.2.
On 02/17/2023, Natera Inc traded for a price of $50.045 per share and a market cap of $5.46Bil. The stock has returned -24.85% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 3 out of 10.
In terms of valuation, Natera Inc has a price-book ratio of 13.45, a EV-to-Ebitda ratio of -10.13 and a price-sales ratio of 5.34.
The price-to-GF Value ratio is 0.54, earning the stock a GF Value rank of 4.
Blend Labs Inc
The guru sold out of their 1,000,000-share investment in NYSE:BLND. Previously, the stock had a 0.32% weight in the equity portfolio. Shares traded for an average price of $1.79 during the quarter.
On 02/17/2023, Blend Labs Inc traded for a price of $1.835 per share and a market cap of $436.19Mil. The stock has returned -80.92% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10. There is insufficient data to calculate the stock’s profitability rating.
In terms of valuation, Blend Labs Inc has a price-book ratio of 2.48, a EV-to-Ebitda ratio of -0.40 and a price-sales ratio of 1.58.
eHealth Inc
The guru sold out of their 750,501-share investment in NAS:EHTH. Previously, the stock had a 0.89% weight in the equity portfolio. Shares traded for an average price of $6.98 during the quarter.
On 02/17/2023, eHealth Inc traded for a price of $9.4948 per share and a market cap of $260.37Mil. The stock has returned -35.69% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 6 out of 10.
In terms of valuation, eHealth Inc has a price-book ratio of 0.41, a EV-to-Ebitda ratio of -5.32 and a price-sales ratio of 0.58.
The price-to-GF Value ratio is 0.23, earning the stock a GF Value rank of 2.
Tivity Health Inc
The guru sold out of their 4,795,310-share investment in NAS:TVTY. Previously, the stock had a 12.34% weight in the equity portfolio. Shares traded for an average price of $32.18 during the quarter.
On 02/17/2023, Tivity Health Inc traded for a price of $32.5 per share and a market cap of $1.62Bil. The stock has returned 23.53% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 6 out of 10.
In terms of valuation, Tivity Health Inc has a price-earnings ratio of 19.01, a price-book ratio of 12.67, a price-earnings-to-growth (PEG) ratio of 8.12, a EV-to-Ebitda ratio of 12.00 and a price-sales ratio of 3.28.
The price-to-GF Value ratio is 1.20, earning the stock a GF Value rank of 1.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
